A mechanistic insight into the anticancer potentials of resveratrol: Current perspectives
Phytotherapy Research · 2024-08 · 38 (8) · 3877-3898
DOI: 10.1002/ptr.8239 ↗At a glance
Übersichtsarbeit in Phytotherapy Research, published online on 2024-05-20. Written by Md Shimul Bhuia and 8 co-authors. Institution: Department of Pharmacy, Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj, Bangladesh. Major MEDLINE topics: Resveratrol, Antineoplastic Agents, Phytogenic. Cited 28 times so far (Crossref); 172 references.
Abstract (original language)
Resveratrol is a widely recognized polyphenolic phytochemical found in various plants and their fruits, such as peanuts, grapes, and berry fruits. It is renowned for its several health advantages. The phytochemical is well known for its anticancer properties, and a substantial amount of clinical evidence has also established its promise as a chemotherapeutic agent. This study focuses on assessing the anticancer properties of resveratrol and gaining insight into the underlying molecular mechanisms. It also evaluates the biopharmaceutical, toxicological characteristics, and clinical utilization of resveratrol to determine its suitability for further development as a reliable anticancer agent. Therefore, the information about preclinical and clinical studies was collected from different electronic databases up‐to‐date (2018–2023). Findings from this study revealed that resveratrol has potent therapeutic benefits against various cancers involving different molecular mechanisms, such as induction of oxidative stress, cytotoxicity, inhibition of cell migration and invasion, autophagy, arresting of the S phase of the cell cycle, apoptotic, anti‐angiogenic, and antiproliferative effects by regulating different molecular pathways including PI3K/AKT, p38/MAPK/ERK, NGFR‐AMPK‐mTOR, and so on. However, the compound has poor oral bioavailability due to reduced absorption; this limitation is overcome by applying nanotechnology (nanoformulation of resveratrol). Clinical application also showed therapeutic benefits in several types of cancer with no serious adverse effects. We suggest additional extensive studies to further check the efficacy, safety, and long‐term hazards. This could involve a larger number of clinical samples to establish the compound as a reliable drug in the treatment of cancer.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pharmacy, Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj, Bangladesh.
- Phytochemistry and Biodiversity Research Laboratory, BioLuster Research Center, Dhaka, Bangladesh.
- Department of Chemistry, The University of Jordan, Amma, Jordan.
- Pharmacy Discipline, Khulna University, Khulna, Bangladesh.
ORCID profiles: Md Shimul Bhuia, Raihan Chowdhury, Mst Asma Akter, Md Arman Ali, Meher Afroz, Md Showkot Akbor, Mohammad S Mubarak, Muhammad Torequl Islam
Cite
APA
Bhuia, M. S., Chowdhury, R., Akter, M. A., Ali, M. A., Afroz, M., Akbor, M. S., Sonia, F. A., Mubarak, M. S., & Islam, M. T. (2024). A mechanistic insight into the anticancer potentials of resveratrol: Current perspectives. Phytotherapy Research, 38(8), 3877-3898. https://doi.org/10.1002/ptr.8239
Vancouver
Bhuia MS, Chowdhury R, Akter MA, Ali MA, Afroz M, Akbor MS, et al. A mechanistic insight into the anticancer potentials of resveratrol: Current perspectives. Phytotherapy Research. 2024;38(8):3877-3898. doi:10.1002/ptr.8239
BibTeX
@article{Bhuia2024,
author = {Bhuia, Md Shimul and Chowdhury, Raihan and Akter, Mst Asma and Ali, Md Arman and Afroz, Meher and Akbor, Md Showkot and Sonia, Fatema Akter and Mubarak, Mohammad S and Islam, Muhammad Torequl},
title = {A mechanistic insight into the anticancer potentials of resveratrol: Current perspectives},
journal = {Phytotherapy Research},
year = {2024},
volume = {38},
number = {8},
pages = {3877--3898},
doi = {10.1002/ptr.8239}
}
EUVIMED